New
Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world.
Description
Grifols Partnership is a CDMO focused in add-value injectable products with a large, international pharmaceutical experience in the development and manufacturing of many types of sterile drug products. Grifols Partnership offers you an integrated project management strategy, during the development and supply of products. The team involves people from all relevant areas to implement the new processes and products at the manufacturing sites.
Type of Drugs Manufactured:
Small Molecule
CDMO Services:
Drug Product Formulation (FDF)
No. of Manufacturing Facilities:
2
High Potent Products capabilities:
OEB 3
Facilities Locations:
Europe
Regulatory Approvals:
FDA (United States);EMA (Europe);ISO;GMP;Health Canada;ANVISA (Brazil)
Current Capacity:
Grifols have FFS ( Form-fill-seal) technology for PP flexible bags ( from 50mL to 1000mL with different ports configurations) with extensive free capacity.
Glass vial lines ( from 2,5mL to 50mL) with extensive free capacity
Glass vial lines ( from 2,5mL to 50mL) with extensive free capacity
Grifols is committed to excellence in the biopharmaceutical sector, ensuring high standards and quality in all its offerings. For more information, please visit grifols.com.
Certification
United States FDA, Europe EMA, ISO, GMP
Manufacturing Information
Facilities
2
Drug Type
Small Molecule
Capabilities
Contact Information
Website
Phone
Twitter (X)
Address
79 Tw Alexander Dr, 4101Sant Cugat del Valles, 90032, United States
Zip/Post Code
90032
AI and Digital Manufacturing Benchmarking Survey
Take this quick 5 minute assessment to benchmark your organisation’s digital and AI maturity — and see how you compare with industry peers.
Latest News
